Purple perilla frutescens extracts containing α-asarone inhibit inflammatory atheroma formation and promote hepatic HDL cholesterol uptake in dyslipidemic apoE-deficient mice
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Dyslipidemia causes metabolic disorders such as atherosclerosis and fatty liver syndrome due to abnormally high blood lipids. Purple perilla frutescens extract (PPE) possesses various bioactive compounds such as α-asarone, chlorogenic acid and rosmarinic acid. This study examined whether PPE and α-asarone improved dyslipidemia-associated inflammation and inhibited atheroma formation in apolipoprotein E (apoE)-deficient mice, an experimental animal model of atherosclerosis. MATERIALS/METHODS: ApoE-deficient mice were fed on high cholesterol-diet (Paigen’s diet) and orally administrated with 10–20 mg/kg PPE and α-asarone for 10 wk. RESULTS: The Paigen’s diet reduced body weight gain in apoE-deficient mice, which was not restored by PPE or α-asarone. PPE or α-asarone improved the plasma lipid profiles in Paigen’s diet-fed apoE-deficient mice, and despite a small increase in high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein (LDL)-cholesterol, and very LDL were significantly reduced. Paigen’s diet-induced systemic inflammation was reduced in PPE or α-asarone-treated apoE-deficient mice. Supplying PPE or α-asarone to mice lacking apoE suppressed aorta atherogenesis induced by atherogenic diet. PPE or α-asarone diminished aorta accumulation of CD68- and/or F4/80-positive macrophages induced by atherogenic diet in apoE-deficient mice. Treatment of apoE-deficient mice with PPE and α-asarone resulted in a significant decrease in plasma cholesteryl ester transfer protein level and an increase in lecithin:cholesterol acyltransferase reduced by supply of Paigen’s diet. Supplementation of PPE and α-asarone enhanced the transcription of hepatic apoA1 and SR-B1 reduced by Paigen’s diet in apoE-deficient mice. CONCLUSIONS: α-Asarone in PPE inhibited inflammation-associated atheroma formation and promoted hepatic HDL-C trafficking in dyslipidemic mice.
Abstract
BACKGROUND/OBJECTIVES: Dyslipidemia causes metabolic disorders such as atherosclerosis and fatty liver syndrome due to abnormally high blood lipids. Purple perilla frutescens extract (PPE) possesses various bioactive compounds such as α-asarone, chlorogenic acid and rosmarinic acid. This study examined whether PPE and α-asarone improved dyslipidemia-associated inflammation and inhibited atheroma formation in apolipoprotein E (apoE)-deficient mice, an experimental animal model of atherosclerosis. MATERIALS/METHODS: ApoE-deficient mice were fed on high cholesterol-diet (Paigen’s diet) and orally administrated with 10–20 mg/kg PPE and α-asarone for 10 wk. RESULTS: The Paigen’s diet reduced body weight gain in apoE-deficient mice, which was not restored by PPE or α-asarone. PPE or α-asarone improved the plasma lipid profiles in Paigen’s diet-fed apoE-deficient mice, and despite a small increase in high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein (LDL)-cholesterol, and very LDL were significantly reduced. Paigen’s diet-induced systemic inflammation was reduced in PPE or α-asarone-treated apoE-deficient mice. Supplying PPE or α-asarone to mice lacking apoE suppressed aorta atherogenesis induced by atherogenic diet. PPE or α-asarone diminished aorta accumulation of CD68- and/or F4/80-positive macrophages induced by atherogenic diet in apoE-deficient mice. Treatment of apoE-deficient mice with PPE and α-asarone resulted in a significant decrease in plasma cholesteryl ester transfer protein level and an increase in lecithin:cholesterol acyltransferase reduced by supply of Paigen’s diet. Supplementation of PPE and α-asarone enhanced the transcription of hepatic apoA1 and SR-B1 reduced by Paigen’s diet in apoE-deficient mice. CONCLUSIONS: α-Asarone in PPE inhibited inflammation-associated atheroma formation and promoted hepatic HDL-C trafficking in dyslipidemic mice.
참고문헌 (42)
- Musunuru K, "Atherogenic dyslipidemia : cardiovascular risk and dietary intervention", Lipids, 45, pp.907~914 (2010)
- Hedayatnia M, "Dyslipidemia and cardiovascular disease risk among the MASHAD study population", Lipids Health Dis, 19, pp.42~ (2020)
- Chiu S, "Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia : a randomized controlled trial", PLoS One, 12, pp.e0170664~ (2017)
- Pedro-Botet J, "Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias", Clin Investig Arterioscler, 32, pp.209~218 (2020)
- Kones R, "Current treatment of dyslipidemia : evolving roles of non-statin and newer drugs", Drugs, 75, pp.1201~1228 (2015)
- Sahebkar A, "New LDL-cholesterol lowering therapies : pharmacology, clinical trials, and relevance to acute coronary syndromes", Clin Ther, 35, pp.1082~1098 (2013)
- Mahley RW, "Apolipoprotein E : far more than a lipid transport protein", Annu Rev Genomics Hum Genet, 1, pp.507~537 (2000)
- Phillips MC, "Apolipoprotein E isoforms and lipoprotein metabolism", IUBMB Life, 66, pp.616~623 (2014)
- Getz GS, "Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall", J Lipid Res, 50(Suppl), pp.S156~S161 (2009)
- Moghadasian MH, "Pathophysiology of apolipoprotein E deficiency in mice : relevance to apo E-related disorders in humans", FASEB J, 15, pp.2623~2630 (2001)
- Rosenson RS, "Cholesterol efflux and atheroprotection : advancing the concept of reverse cholesterol transport", Circulation, 125, pp.1905~1919 (2012)
- Rochlani Y, "Metabolic syndrome : pathophysiology, management, and modulation by natural compounds", Ther Adv Cardiovasc Dis, 11, pp.215~225 (2017)
- Ji X, "Bioactive compounds from herbal medicines to manage dyslipidemia", Biomed Pharmacother, 118, pp.109338~ (2019)
- Hu Y, "Medicinal and edible plants in the treatment of dyslipidemia : advances and prospects", Chin Med, 17, pp.113~ (2022)
- Yu H, "Phytochemical and phytopharmacological review of Perilla frutescens L. (Labiatae), a traditional edible-medicinal herb in China", Food Chem Toxicol, 108, pp.375~391 (2017)
- Liu S, "A comprehensive review of the botany, ethnopharmacology, phytochemistry, pharmacology, toxicity and quality control of Perillae Fructus", J Ethnopharmacol, 304, pp.116022~ (2023)
- Park SH, "Purple perilla extracts with α-asarone enhance cholesterol efflux from oxidized LDL-exposed macrophages", Int J Mol Med, 35, pp.957~965 (2015)
- Park SH, "Purple perilla extracts allay ER stress in lipid-laden macrophages", PLoS One, 9, pp.e110581~ (2014)
- Paek JH, "Rapid identification of aldose reductase inhibitory compounds from Perilla frutescens", BioMed Res Int, 2013, pp.679463~ (2013)
- Wang Z, "Competitive binding experiments can reduce the false positive results of affinity-based ultrafiltration-HPLC: a case study for identification of potent xanthine oxidase inhibitors from Perilla frutescens extract", J Chromatogr B Analyt Technol Biomed Life Sci, 1048, pp.30~37 (2017)
- Rodríguez-Páez L, "Alpha-asarone inhibits HMGCoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats", Phytomedicine, 10, pp.397~404 (2003)
- Hwang SH, "Rapid high performance liquid chromatography determination and optimization of extraction parameters of the α-asarone isolated from Perilla frutescens L", Molecules, 22, pp.270~ (2017)
- Nakashima Y, "ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree", Arterioscler Thromb, 14, pp.133~140 (1994)
- Lloyd CM, "Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for macrophage markers in murine spleen and liver", J Immunol Methods, 334, pp.70~81 (2008)
- Lo Sasso G, "The Apoe(-", -)mouse model : a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reduction, 2016, pp.14, 146~
- De Giorgi M, "Targeting the Apoa1 locus for liver-directed gene therapy", Mol Ther Methods Clin Dev, 21, pp.656~669 (2021)
- Ganesan LP, "Scavenger receptor B1, the HDL receptor, is expressed abundantly in liver sinusoidal endothelial cells", Sci Rep, 6, pp.20646~ (2016)
- Leiva A, "Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism", Atherosclerosis, 217, pp.299~307 (2011)
- Mahley RW, "from cardiovascular disease to neurodegenerative disorders", J Mol Med(Berl), 94, pp.739~746 (2016)
- Chowaniec Z, "Plasma lipid transfer proteins : the role of PLTP and CETP in atherogenesis", Adv Clin Exp Med, 27, pp.429~436 (2018)
- Manthei KA, "Structural analysis of lecithin : cholesterol acyltransferase bound to high density lipoprotein particles", Commun Biol, 3, pp.28~ (2020)
- Rong S, "Procyanidins extracted from the litchi pericarp attenuate atherosclerosis and hyperlipidemia associated with consumption of a high fat diet in apolipoprotein-E knockout mice", Biomed Pharmacother, 97, pp.1639~1644 (2018)
- Li J, "Resveratrol improves endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice", J Nutr Biochem, 67, pp.63~71 (2019)
- Wu C, "Chlorogenic acid protects against atherosclerosis in ApoE-", - mice and promotes cholesterol efflux from RAW264.7 macrophages, 2014, pp.9, e95452~
- Park SH, "α-Asarone blocks 7β-hydroxycholesterol-exposed macrophage injury through blocking elF2α phosphorylation and prompting beclin-1-dependent autophagy", Oncotarget, 8, pp.7370~7383 (2017)
- Park SH, "Dietary compound α-asarone alleviates ER stress-mediated apoptosis in 7β-hydroxycholesterol-challenged macrophages", Mol Nutr Food Res, 60, pp.1033~1047 (2016)
- Farrell N, "Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice", Food Funct, 6, pp.1278~1287 (2015)
- Xu M, "Peanut skin extract ameliorates high-fat diet-induced atherosclerosis by regulating lipid metabolism, inflammation reaction and gut microbiota in ApoE-", -mice, 2022, pp.154, 111014~
- Olszanecki R, "Effect of curcumin on atherosclerosis in apoE", LDLR-double knockout mice, 2005, pp.56, 627~635
- Huang W, "Cannabis seed oil alleviates experimental atherosclerosis by ameliorating vascular inflammation in apolipoprotein-E-deficient mice", J Agric Food Chem, 69, pp.9102~9110 (2021)
- Peng Y, "Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice : role of reverse cholesterol transport", Phytomedicine, 62, pp.152935~ (2019)
- Millar CL, "Effects of dietary flavonoids on reverse cholesterol transport, HDL metabolism, and HDL function", Adv Nutr, 8, pp.226~239 (2017)